Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

The use of whole-genome sequencing in cluster investigation of an MDR-TB outbreak.

Lalor MK, Casali N, Walker TM, Anderson LF, Davidson JA, Ratna N, Mullarkey C, Gent M, Foster K, Brown T, Magee J, Barrett A, Crook DW, Drobniewski F, Thomas HL, Abubakar I.

Eur Respir J. 2018 May 10. pii: 1702313. doi: 10.1183/13993003.02313-2017. [Epub ahead of print] No abstract available.

PMID:
29748309
2.

Reduction in tuberculosis incidence in the UK from 2011 to 2015: a population-based study.

Thomas HL, Harris RJ, Muzyamba MC, Davidson JA, Lalor MK, Campbell CNJ, Anderson SR, Zenner D.

Thorax. 2018 Apr 19. pii: thoraxjnl-2017-211074. doi: 10.1136/thoraxjnl-2017-211074. [Epub ahead of print]

PMID:
29674389
3.

The challenge of estimating tuberculosis mortality accurately in England and Wales.

Lalor MK, Mohiyuddin T, Uddin T, Thomas HL, Lipman M, Campbell CNJ.

Int J Tuberc Lung Dis. 2018 May 1;22(5):572-578. doi: 10.5588/ijtld.17.0695.

PMID:
29663964
4.

Investigating a tuberculosis cluster among Filipino health care workers in a low-incidence country.

Davidson JA, Fulton N, Thomas HL, Lalor MK, Zenner D, Brown T, Murphy S, Anderson LF.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):252-257. doi: 10.5588/ijtld.17.0620.

PMID:
29471901
5.

Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.

Loutet MG, Davidson JA, Brown T, Dedicoat M, Thomas HL, Lalor MK.

Emerg Infect Dis. 2018 Mar;24(3):524-533. doi: 10.3201/eid2403.171362.

6.

Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV.

Winter JR, Stagg HR, Smith CJ, Brown AE, Lalor MK, Lipman M, Pozniak A, Skingsley A, Kirwan P, Yin Z, Thomas HL, Delpech V, Abubakar I.

AIDS. 2017 Nov 13;31(17):2403-2413. doi: 10.1097/QAD.0000000000001635.

PMID:
28857827
7.

Recent household transmission of tuberculosis in England, 2010-2012: retrospective national cohort study combining epidemiological and molecular strain typing data.

Lalor MK, Anderson LF, Hamblion EL, Burkitt A, Davidson JA, Maguire H, Abubakar I, Thomas HL.

BMC Med. 2017 Jun 13;15(1):105. doi: 10.1186/s12916-017-0864-y.

8.

Twenty years and counting: epidemiology of an outbreak of isoniazid-resistant tuberculosis in England and Wales, 1995 to 2014.

Smith CM, Trienekens SC, Anderson C, Lalor MK, Brown T, Story A, Fry H, Hayward AC, Maguire H.

Euro Surveill. 2017 Feb 23;22(8). pii: 30467. doi: 10.2807/1560-7917.ES.2017.22.8.30467.

9.

Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.

Davidson JA, Loutet MG, O'Connor C, Kearns C, Smith RM, Lalor MK, Thomas HL, Abubakar I, Zenner D.

Emerg Infect Dis. 2017 Mar;23(3):377-386. doi: 10.3201/eid2303.161408.

10.

Insidious Risk of Severe Mycobacterium chimaera Infection in Cardiac Surgery Patients.

Chand M, Lamagni T, Kranzer K, Hedge J, Moore G, Parks S, Collins S, Del Ojo Elias C, Ahmed N, Brown T, Smith EG, Hoffman P, Kirwan P, Mason B, Smith-Palmer A, Veal P, Lalor MK, Bennett A, Walker J, Yeap A, Isidro Carrion Martin A, Dolan G, Bhatt S, Skingsley A, Charlett A, Pearce D, Russell K, Kendall S, Klein AA, Robins S, Schelenz S, Newsholme W, Thomas S, Collyns T, Davies E, McMenamin J, Doherty L, Peto TE, Crook D, Zambon M, Phin N.

Clin Infect Dis. 2017 Feb 1;64(3):335-342. doi: 10.1093/cid/ciw754. Epub 2016 Dec 7.

11.

Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.

Aldridge RW, Zenner D, White PJ, Williamson EJ, Muzyamba MC, Dhavan P, Mosca D, Thomas HL, Lalor MK, Abubakar I, Hayward AC.

Lancet. 2016 Nov 19;388(10059):2510-2518. doi: 10.1016/S0140-6736(16)31008-X. Epub 2016 Oct 11.

12.

Recent TB transmission, clustering and predictors of large clusters in London, 2010-2012: results from first 3 years of universal MIRU-VNTR strain typing.

Hamblion EL, Le Menach A, Anderson LF, Lalor MK, Brown T, Abubakar I, Anderson C, Maguire H, Anderson SR; Public Health England Strain Typing Project Board.

Thorax. 2016 Aug;71(8):749-56. doi: 10.1136/thoraxjnl-2014-206608.

13.

Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007-2012.

Shah NM, Davidson JA, Anderson LF, Lalor MK, Kim J, Thomas HL, Lipman M, Abubakar I.

BMC Infect Dis. 2016 May 6;16:195. doi: 10.1186/s12879-016-1521-3.

14.

Towards better guidance on caseload thresholds to promote positive tuberculosis treatment outcomes: a cohort study.

Stagg HR, Abubakar I, Brown J, Lalor MK, Thomas HL, Mohiyuddin T, Pedrazzoli D, Merle CS.

BMC Med. 2016 Mar 23;14:52. doi: 10.1186/s12916-016-0592-8.

15.

TB in healthcare workers in the UK: a cohort analysis 2009-2013.

Davidson JA, Lalor MK, Anderson LF, Tamne S, Abubakar I, Thomas HL.

Thorax. 2017 Jul;72(7):654-659. doi: 10.1136/thoraxjnl-2015-208026. Epub 2016 Feb 17.

PMID:
26888779
16.

Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007-12, with whole pathogen genome sequences: an observational study.

Walker TM, Lalor MK, Broda A, Ortega LS, Morgan M, Parker L, Churchill S, Bennett K, Golubchik T, Giess AP, Del Ojo Elias C, Jeffery KJ, Bowler ICJW, Laurenson IF, Barrett A, Drobniewski F, McCarthy ND, Anderson LF, Abubakar I, Thomas HL, Monk P, Smith EG, Walker AS, Crook DW, Peto TEA, Conlon CP.

Lancet Respir Med. 2014 Apr;2(4):285-292. doi: 10.1016/S2213-2600(14)70027-X. Epub 2014 Mar 4.

17.

Factors affecting immunogenicity of BCG in infants, a study in Malawi, The Gambia and the UK.

Hur YG, Gorak-Stolinska P, Lalor MK, Mvula H, Floyd S, Raynes J, Ben-Smith A, Fitchett JR, Flanagan KL, Burl S, Ota MO, Crampin AC, Smith SG, Dockrell HM.

BMC Infect Dis. 2014 Apr 5;14:184. doi: 10.1186/1471-2334-14-184.

18.

Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.

Hur YG, Crampin AC, Chisambo C, Kanyika J, Houben R, Ndhlovu R, Mzembe T, Lalor MK, Saul J, Branson K, Stanley C, Ngwira B, French N, Ottenhoff TH, Dockrell HM, Gorak-Stolinska P.

Clin Vaccine Immunol. 2014 Feb;21(2):133-42. doi: 10.1128/CVI.00620-13. Epub 2013 Nov 27.

19.

Combination of cytokine responses indicative of latent TB and active TB in Malawian adults.

Hur YG, Gorak-Stolinska P, Ben-Smith A, Lalor MK, Chaguluka S, Dacombe R, Doherty TM, Ottenhoff TH, Dockrell HM, Crampin AC.

PLoS One. 2013 Nov 18;8(11):e79742. doi: 10.1371/journal.pone.0079742. eCollection 2013.

20.

Risk factors associated with default from multi- and extensively drug-resistant tuberculosis treatment, Uzbekistan: a retrospective cohort analysis.

Lalor MK, Greig J, Allamuratova S, Althomsons S, Tigay Z, Khaemraev A, Braker K, Telnov O, du Cros P.

PLoS One. 2013 Nov 6;8(11):e78364. doi: 10.1371/journal.pone.0078364. eCollection 2013.

Supplemental Content

Loading ...
Support Center